NCT05178914View on ClinicalTrials.gov

Personalized Medicine Using Coronary Microvascular Function Measured in Patient With Percutaneous Coronary Intervention in Angina

NARecruitingINTERVENTIONAL
Enrollment

280

Participants

Timeline

Start Date

March 31, 2022

Primary Completion Date

March 31, 2025

Study Completion Date

March 31, 2026

Conditions
Coronary Microvascular Disease
Interventions
PROCEDURE

Treatment adaptation

Patients will benefit from intensified treatment or de escalation treatment according to the result of the index of microcirculatory resistance

Trial Locations (1)

38700

RECRUITING

CHU Grenoble Alpes, La Tronche

All Listed Sponsors
lead

University Hospital, Grenoble

OTHER

NCT05178914 - Personalized Medicine Using Coronary Microvascular Function Measured in Patient With Percutaneous Coronary Intervention in Angina | Biotech Hunter | Biotech Hunter